BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17650445)

  • 1. Monoclonal gammopathy: natural history studied with a retrospective approach.
    Steingrimsdottir H; Haraldsdottir V; Olafsson I; Gudnason V; Ogmundsdottir HM
    Haematologica; 2007 Aug; 92(8):1131-4. PubMed ID: 17650445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
    Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
    Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
    Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of paraproteins by immunoturbidimetry and electrophoresis followed by scanning densitometry.
    Sinclair D; Ballantyne F; Shanley S; Caine E; O'Reilly D; Shenkin A
    Ann Clin Biochem; 1990 Jul; 27 ( Pt 4)():335-7. PubMed ID: 2119564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia.
    Kyle RA; Benson J; Larson D; Therneau T; Dispenzieri A; Melton Iii LJ; Rajkumar SV
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):17-8. PubMed ID: 19362962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biclonal paraproteinemia: macroglobulinemia-myeloma].
    Rabago Torre L; Velo Bellver JL; Clemente Ricote G; López de la Riva M; Alcalá-Santaella R
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):50-5. PubMed ID: 6813927
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.
    Landgren O; Kyle RA; Pfeiffer RM; Katzmann JA; Caporaso NE; Hayes RB; Dispenzieri A; Kumar S; Clark RJ; Baris D; Hoover R; Rajkumar SV
    Blood; 2009 May; 113(22):5412-7. PubMed ID: 19179464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
    McMaster ML; Kristinsson SY; Turesson I; Björkholm M; Landgren O
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):19-22. PubMed ID: 19362963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy of undetermined significance.
    Kyle RA
    Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients.
    Gore ME; Riches PG; Kohn J
    J Clin Pathol; 1979 Apr; 32(4):313-7. PubMed ID: 109473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
    Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
    Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum markers in the differential diagnosis of Waldenstrom macroglobulinemia and other IgM monoclonal gammopathies.
    Zou H; Yang R; Liao ZX; Qin TD; Chen P; Zhang BY; Cao YP; Huang HF
    J Clin Lab Anal; 2019 Mar; 33(3):e22827. PubMed ID: 30485557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclasses IgG1--IgG4 in 84 sera with IgG paraprotein.
    Tichý M; Hrncír Z; Mracek J
    Neoplasma; 1978; 25(1):107-10. PubMed ID: 634402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraproteins: a regional South Australian experience.
    Roberts-Thomson PJ; Nikoloutsopoulos T; Smith AJ
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):187-95. PubMed ID: 12587843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory component is bound to the paraproteins in sera of IgA and IgM gammopathies.
    Bouvet JP; Hocini H; Iscaki S
    Scand J Immunol; 1992 Jan; 35(1):79-83. PubMed ID: 1734498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
    Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
    Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
    Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
    Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria.
    Belouni R; Allam I; Cherguelaine K; Berkani L; Belaid B; Berkouk Y; Nekkal S; Saidani M; Belhani M; Ghaffor M; Djidjik R
    Curr Res Transl Med; 2020 Apr; 68(2):67-70. PubMed ID: 31761679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.